Key result
Hannan clinical risk model predicts long-term mortality more accurately than actuarial models in CABG patients.
Why the study?
Does a clinical risk model improve long-term mortality prediction compared to a traditional actuarial model in post-CABG patients?
Observational (n=1,028)
Does a clinical risk model improve long-term mortality prediction compared to a traditional actuarial model in post-CABG patients?
Clinical risk models provide superior long-term mortality prediction post-CABG compared to simple actuarial models, particularly for patients with renal dysfunction.
Clinical models may better predict long-term CABG mortality than actuarial ones; supports risk stratification but leaves impact on outcomes open.
BACKGROUND/AIM: Clinical risk models are commonly used to predict short-term coronary artery bypass grafting (CABG) mortality but are less commonly used to predict long-term mortality. The added value of long-term mortality clinical risk models over traditional actuarial models has not been evaluated. To address this, the predictive performance of a long-term clinical risk model was compared with that of an actuarial model to identify the clinical variable(s) most responsible for any differences observed. METHODS: Long-term mortality for 1028 CABG patients was estimated using the Hannan New York State clinical risk model and an actuarial model (based on age, gender, and race/ethnicity). Vital status was assessed using the Social Security Death Index. Observed/expected (O/E) ratios were calculated, and the models' predictive performances were compared using a nested c-index approach. Linear regression analyses identified the subgroup of risk factors driving the differences observed. RESULTS: Mortality rates were 3%, 9%, and 17% at one-, three-, and five years, respectively (median follow-up: five years). The clinical risk model provided more accurate predictions. Greater divergence between model estimates occurred with increasing long-term mortality risk, with baseline renal dysfunction identified as a particularly important driver of these differences. CONCLUSIONS: Long-term mortality clinical risk models provide enhanced predictive power compared to actuarial models. Using the Hannan risk model, a patient's long-term mortality risk can be accurately assessed and subgroups of higher-risk patients can be identified for enhanced follow-up care. More research appears warranted to refine long-term CABG clinical risk models.
No takes yet. Share an insight, caveat, or question.
Carr et al. (2015) conducted an observational in Coronary artery bypass grafting (CABG) (n=1,028). Hannan New York State clinical risk model vs. Actuarial model (based on age, gender, and race/ethnicity) was evaluated on Long-term mortality predictive performance. The Hannan clinical risk model provided more accurate long-term mortality predictions than an actuarial model in CABG patients, who had an overall 5-year mortality rate of 17%.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: